Physician profile
Brian Lebovitz
NPI 1134173909
$3,264.21
in general payments reported to CMS, 2019-2025
21 companies · $882 in 2025
The $882 reported for 2025 was more than what 77% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $162 · 2021: $189 · 2022: $399 · 2023: $733 · 2024: $696 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,311.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $853.45 | 2019-2025 | |
| Aerin Medical INC. | $649.16 | 2020-2025 | |
| Glaxosmithkline, LLC. | $496.58 | 2019-2025 | Nucala, Trelegy Ellipta |
| Optinose US, INC. | $209.07 | 2019-2024 | |
| Alk-Abello, INC | $185.43 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Novartis Pharmaceuticals Corporation | $169.25 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $162.41 | 2024-2025 | Cuvitru, Eohilia |
| Csl Behring | $112.19 | 2020-2025 | Hizentra, Haegarda |
| Hikma Pharmaceuticals USA | $65.28 | 2024 | Ryaltris |
| Leo Pharma INC. | $59.71 | 2022-2023 | Adbry |
| Davol INC. | $42.48 | 2021 | |
| Stryker Corporation | $41.78 | 2025 | Xpress Loprofile |
| Grifols USA, LLC | $40.54 | 2025 | Xembify |
| Regeneron Healthcare Solutions, INC. | $34.27 | 2025 | Dupixent |
| Amgen INC. | $32.00 | 2022-2023 | Tezspire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $31.83 | 2024 | Airsupra |
| Blueprint Medicines Corporation | $19.78 | 2024 | Ayvakit |
| Organon LLC | $18.30 | 2025 | |
| Smith+Nephew, INC. | $16.36 | 2025 | Tula |
| Medtronic USA, INC. | $12.90 | 2019 | |
| Ethicon US, LLC | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lebovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.